RecruitingNot ApplicableNCT06526598

Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) Trial

A Cluster Randomized Trial on Inspiratory Effort-Based Pressure Support Adjustment Strategy in Patients Undergoing Assisted Mechanical Ventilation


Sponsor

Capital Medical University

Enrollment

619 participants

Start Date

Jan 19, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The Inspiratory effort-Targeted Pressure Support Ventilation (IT-PSV) is a cluster randomized controlled trial. Its main aim is to determine whether an inspiratory effort-targeted pressure support setting strategy, compared to the traditional tidal volume and respiratory rate target, can improve clinical outcomes in adult participants undergoing pressure support ventilation. The investigators propose a physiological-oriented assisted ventilation management that, if found effective, could potentially change the clinical practice for mechanical ventilation.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called PMI-targeted pressure support setting and adjustment and a procedure called VT/RR-targeted pressure support setting and adjustment for people with acute hypoxic respiratory failure, critical care, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPMI-targeted pressure support setting and adjustment

During PSV, the pressure support is set and adjusted to a PMI target between 0 and 2 cmH2O.

PROCEDUREVT/RR-targeted pressure support setting and adjustment

During PSV, pressure support is set and adjusted according to a VT/RR target of VT between 6 and 8 ml/kg predicted body weight, RR between 20 and 35 breaths/min, and no signs of respiratory distress.


Locations(1)

Beijing Shijitan Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06526598


Related Trials